Hosted on MSN5mon
Eli Lilly's Once-Weekly Insulin Shows Non-Inferior Blood Sugar Reduction Vs Frequently Used Daily Insulins In Long Term Trials
Thursday, Eli Lilly and Co (NYSE ... the efficacy and safety of once-weekly efsitora compared to once-daily insulin glargine for 52 weeks in insulin naïve patients. The trial met its primary ...
pharmaphorum2d
Lilly slashes insulin price 70%, patient cost cap now $35
Indianapolis-based drugmaker Eli Lilly and Company has announced price ... Additionally, Lilly is launching Rezvoglar (insulin glargine-aglr) injection, a basal insulin that is biosimilar to ...
Hosted on MSN5mon
Eli Lilly's Weekly Insulin Shot Meets Two Late-Stage Study Goals
Eli Lilly LLY announced positive topline results ... The QWINT-1 study compared efsitora to daily injections of Sanofi’s SNY Lantus (insulin glargine) for 52 weeks in T2D patients using basal ...
The Associated Press on MSN26d
Newsom Committed California to Making Its Own Insulin. It’s at Least a Year Behind His Schedule
Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind schedule ...
pharmaphorum8d
Lilly preps for rollout of its connected diabetes system
After years of preparation, Eli Lilly is on the brink of launching ... including Humalog and Lyumjev, both insulin lispro-based, and insulin glargine brand Basaglar. "Despite technological ...
THE WEEK1y
Eli Lilly's insulin price cap: How much will the drug cost?
Drug company Eli Lilly announced it will cut the price of its insulin by 70 percent. How much will the drug cost and what does this mean for people with diabetes? Here's everything you need to ...
BBC29d
Drugs giant Eli Lilly caps monthly insulin costs in US at $35
Drug giant Eli Lilly has announced a $35 (£30) cap on the monthly costs patients face for insulin in the US, responding to outcry over the soaring cost of the diabetes medication. More than eight ...